- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01044043
Prevalence and Subjective Impairment of Quality of Life (QoL) Due to Dermatologic Diseases in Internal Medicine Patients
This is a 3 months single centre clinical patient-oriented study to evaluate the prevalence and impairment in QOL of dermatologic diseases in patients hospitalised in internal medicine.
Up to 200 patients hospitalised at the division of internal medicine for any reason are going to be offered participation by a patient information form given to patients at the time of admission, as well as oral information about the study. Written informed consent will be obtained by the investigators after patients have had adequate time to consider their participation in the study.
Participating patients will be examined clinically for dermatologic pathologies at a single visit. In the case of signs of dermatologic disease, investigators are going to recommend further diagnostic procedures to the physician in charge and/or the referring physician, depending on the urgency of the suspected diagnosis. This procedure is meant to avoid giving referring physicians the impression that active patient acquisition for the department of Dermatology is an aim of this study. Diagnostic procedures that are performed upon suspicion of a specific dermatologic disease at the Division of Internal Medicine are going to be performed during the hospitalisation period. All other diagnostic or operative procedures are going to be advised to the referring physician.
Study participants are going to be interviewed by the investigators about impairment in QOL of their illnesses. Two separate questionnaires are going to be filled in by each participant. For measurement of general QOL, the widely used SF-12 questionnaire (8 questions) is going to be used. To measure specific impairment in QOL by dermatologic disease, participants are going to be asked to fill in the DLQI (Dermatology life quality index, 10 questions). Photographic documentation of specific identified lesions will be made and pictures stored exclusively in the secured electronic patient file (KISIM). Medication and all identified diseases will be noted. All diagnostically useful information is going to be recorded in the patient file and transmitted to the referring physician in the discharge letter.
Study Overview
Status
Intervention / Treatment
Study Type
Enrollment (Anticipated)
Contacts and Locations
Study Locations
-
-
-
Zurich, Switzerland
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Sampling Method
Study Population
Description
Inclusion criteria: Patients will be eligible for enrolment if they fulfil the following criteria:
- Male or female patients, age ? 18 years of age and
- Hospitalised at the Division of Internal Medicine, University Hospital Zurich
- Patients must be able to give written informed consent before any trial-specific procedures are performed (see Section 12.2).
Exclusion criteria: Patients will be excluded from the study if they fulfill any of the following criteria:
- Ability to communicate orally severely impaired due to any reason, namely illness or inability to speak German.
- Terminal patients or other patients where participation in a visit with oral and physical examination would represent an unreasonable exertion.
- Pregnant women
Study Plan
How is the study designed?
Design Details
Collaborators and Investigators
Sponsor
Study record dates
Study Major Dates
Study Start
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Estimate)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- PREV_DERM_INTMED
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Dermatologic Disease of Inpatients in Internal Medicine
-
University Hospital, MontpellierCompletedPatient Hospitalized in Internal Medicine UnitFrance
-
Hopital LariboisièreCompletedAcute Medical Patients Hospitalized in Internal Medicine
-
Peking Union Medical College HospitalNational Institute of Hospital Administration, National Health CommissionCompletedNutritional Status of Chinese Inpatients;Nutritional Service Capacity of Medical Institutions in ChinaChina
-
Peking Union Medical College HospitalNational Institute of Hospital Administration, National Health CommissionNot yet recruitingNutritional Status of Chinese Inpatients | Nutritional Service Capacity of Medical Institutions in ChinaChina
-
University Hospital, Clermont-FerrandUnknownPatient Hospitalized in Disease Infectious Unit | Patient Hospitalized in Intensive Reanimation Unit | Patient Hopsitalized in Internal Medicine UnitFrance
-
Assistance Publique - Hôpitaux de ParisUniversity of Paris 5 - Rene DescartesCompletedProfessionals and Patients in the Department of Physical Medicine and RehabilitationFrance
-
Maastricht University Medical CenterCompletedTelemedicine | Pulmonary Disease | Internal MedicineNetherlands
-
University of ViennaMedical University of ViennaCompletedDermatologic Disorders | Disorder of Cholesterol Metabolism
-
Heba A YassaEnrolling by invitationthe Study Focus on the Uses of Telephone and Other New Technology in Medicine, Diagnosis and TreatmentEgypt
-
University of SheffieldCompletedQuality of Life | Psychological Distress | Body Image | Dermatologic DiseaseUnited Kingdom
Clinical Trials on clinical examination and quality of life questionnaire
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)Active, not recruitingMalignant Head and Neck NeoplasmUnited States
-
Centre Hospitalier Universitaire DijonCompletedCovid19 | ARDS | Functional RecoveryFrance
-
Torbay and South Devon NHS Foundation TrustUnknown
-
Asian Institute of Gastroenterology, IndiaAll India Institute of Medical Sciences, New Delhi; Aalborg University Hospital and other collaboratorsRecruiting
-
Ohio State University Comprehensive Cancer CenterRecruitingMetastatic Malignant Solid Neoplasm | Metastatic Malignant Neoplasm in the BrainUnited States
-
GlaxoSmithKlineCompletedWiskott-Aldrich SyndromeUnited States
-
University Hospital, MontpellierPediatric and Congenital Cardiology Department of Necker-enfant malades University...CompletedQuality of Life Assessment of Children With Congenital Heart Disease Aged 5 to 7 Years (QoL-CHD-5-7)Congenital Heart DiseaseFrance
-
ECOG-ACRIN Cancer Research GroupNational Cancer Institute (NCI)Active, not recruitingMetastatic Renal Cell Carcinoma | Chronic Kidney Disease | Stage IV Renal Cell Cancer AJCC v8 | Cardiovascular Disorder | Metastatic Thyroid Gland Medullary Carcinoma | Stage IV Thyroid Gland Medullary Carcinoma AJCC v8 | Stage IVA Thyroid Gland Medullary Carcinoma AJCC v8 | Stage IVB Thyroid Gland... and other conditionsUnited States
-
Hamilton Health Sciences CorporationFirestone Institute for Respiratory HealthCompletedNasal Lavage Fluid | Eosinophils | Reproducibility of ResultsCanada
-
Nantes University HospitalUniversité d'Angers (Angers, France); Association Neurofibromatoses et RecklinghaüsenCompletedNeurofibromatosis Type 1France